NasdaqCM:CRSA

Stock Analysis Report

Executive Summary

Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination.

Snowflake

Fundamentals

Limited growth with weak fundamentals.

Share Price & News

How has Crescent Acquisition's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

CRSA

2.2%

US Capital Markets

1.0%

US Market


1 Year Return

n/a

CRSA

1.9%

US Capital Markets

6.7%

US Market

Return vs Industry: Insufficient data to determine how CRSA performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how CRSA performed against the US Market.


Share holder returns

CRSAIndustryMarket
7 Day0%2.2%1.0%
30 Day-0.1%-4.7%-1.8%
90 Day0.5%-3.3%-1.8%
1 Yearn/a4.2%1.9%9.1%6.7%
3 Yearn/a51.6%43.1%46.1%36.6%
5 Yearn/a78.2%61.8%66.9%48.6%

Price Volatility Vs. Market

How volatile is Crescent Acquisition's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Crescent Acquisition undervalued based on future cash flows and its price relative to the stock market?

151.59x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Undervalued: CRSA ($9.83) is trading above our estimate of fair value ($0.01)

Significantly Undervalued: CRSA is trading above our estimate of fair value.


Price Based on Earnings

PE vs Industry: CRSA is poor value based on its PE Ratio (151.6x) compared to the Capital Markets industry average (37x).

PE vs Market: CRSA is poor value based on its PE Ratio (151.6x) compared to the US market (17.5x).


Price Based on Expected Growth

Low PEG Ratio: Insufficient data to calculate CRSA's PEG Ratio to determine if it is good value.


Price Based on Value of Assets

PB vs Industry: CRSA is overvalued based on its PB Ratio (61.4x) compared to the US Capital Markets industry average (6.5x).


Next Steps

Future Growth

How is Crescent Acquisition expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

18.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Earnings vs Savings Rate: CRSA's forecast earnings growth (18.8% per year) is above the savings rate (2.7%).

Earnings vs Market: CRSA's earnings (18.8% per year) are forecast to grow faster than the US market (14.5% per year).

High Growth Earnings: CRSA's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if CRSA's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if CRSA's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Estimates


Future Return on Equity

High Future ROE: Insufficient data to determine if CRSA's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Crescent Acquisition performed over the past 5 years?

15.4%

Historical Diversified Financials annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if CRSA's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare CRSA's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.

Earnings vs Industry: Insufficient data to determine if CRSA's earnings growth over the past year exceeded the Capital Markets industry average.


Return on Equity

High ROE: Whilst CRSA's Return on Equity (24.32%) is high, this metric is skewed due to their high level of debt.


Return on Assets

ROA vs Industry: CRSA's Return on Assets is below or equal to the Capital Markets industry average last year.


Return on Capital Employed

ROCE Improving: CRSA is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Crescent Acquisition's financial position? (This company is analysed differently as a bank or financial institution)


Financial Position Analysis


Debt to Equity History and Analysis


Balance Sheet

Inventory Level: CRSA has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if CRSA's debt is covered by short term assets.


Financial Institutions Analysis

Asset Level: CRSA's level of assets compared to its equity is very high.

Allowance for Bad Loans: Insufficient data to determine if CRSA has a sufficient allowance for bad loans.

Low Risk Liabilities: CRSA reports no customer deposits, loans are made up entirely of externally borrowed funds.

Loan Level: Insufficient data to determine if CRSA has an acceptable proportion of non-loan assets held.

Low Risk Deposits: CRSA has advanced significantly more loans than the customer deposits it holds.

Level of Bad Loans: Insufficient data to determine if CRSA has an appropriate level of bad loans.


Next Steps

Dividend

What is Crescent Acquisition's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage2.4%forecastin3Yearsn/a

Current dividend yield vs market & industry


Dividend Yield and Payments Analysis

Notable Dividend: Unable to evaluate CRSA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CRSA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if CRSA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CRSA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CRSA's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Crescent Acquisition's salary, the management and board of directors tenure and is there insider trading?

1.9yrs

Average management tenure


CEO

Todd Purdy (44yo)

0.9yrs

Tenure

0

Mr. Todd M. Purdy has been Chief Executive Officer of Crescent Funding Inc. since November 2018 and serves as its Director. Mr. Purdy is a seasoned private equity investor with years of investment industry ...


Management Age and Tenure

1.9yrs

Average Tenure

48.5yo

Average Age

Experienced Management: CRSA's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Bob Beyer (59yo)

    Executive Chairman

    • Tenure: 0.9yrs
  • Todd Purdy (44yo)

    CEO & Director

    • Tenure: 0.9yrs
  • Chris Wright (47yo)

    President

    • Tenure: 1.9yrs
  • George Hawley (51yo)

    General Counsel & Secretary

    • Tenure: 1.9yrs
  • Mike Wilhelms (50yo)

    • Tenure: 1.9yrs
  • Al Hassanein (39yo)

    Chief Financial Officer

    • Tenure: 0yrs

Board Members

  • Bob Beyer (59yo)

    Executive Chairman

    • Tenure: 0.9yrs
  • Jean-Marc Chapus (59yo)

    Chairman of the Board

    • Tenure: 1.9yrs
  • Todd Purdy (44yo)

    CEO & Director

    • Tenure: 0.9yrs

Company Information

Crescent Acquisition Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Crescent Acquisition Corp.
  • Ticker: CRSA
  • Exchange: NasdaqCM
  • Founded: 2017
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Market Cap: US$307.188m
  • Shares outstanding: 31.25m
  • Website: https://www.crescentspac.com

Location

  • Crescent Acquisition Corp.
  • 11100 Santa Monica Boulevard
  • Suite 2000
  • Los Angeles
  • California
  • 90025
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRSA.UNasdaqCM (Nasdaq Capital Market)Unit (1 Ordinary share Cls A and 1/2 Wrt)USUSDMar 2019
CRSANasdaqCM (Nasdaq Capital Market)YesClass A Common StockUSUSDApr 2019

Biography

Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The company was formerly known as Cres ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 03:13
End of Day Share Price2019/10/07 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. ALL RIGHTS RESERVED.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)